Study on Examination of Therapeutic Efficacy and Potential Mechanisms of Yoga Treatment in Schizophrenia
SATYAM
Examination of Therapeutic Efficacy and Potential Mechanisms of Yoga Treatment in Schizophrenia
1 other identifier
interventional
96
1 country
1
Brief Summary
The aim of this study is to examine whether yoga is efficacious as an add-on treatment for negative symptoms of schizophrenia in a randomized multi-centric trial and also to examine functional brain changes associated with self-reflection after treatment with yoga.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable schizophrenia
Started Nov 2016
Typical duration for not_applicable schizophrenia
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 11, 2016
CompletedFirst Submitted
Initial submission to the registry
December 15, 2017
CompletedFirst Posted
Study publicly available on registry
December 20, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2020
CompletedAugust 28, 2020
August 1, 2020
3.6 years
December 15, 2017
August 27, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Improvement in negative symptoms in patients with schizophrenia
Schizophrenia patients receiving yoga as add-on treatment will have significant improvement in negative symptoms after yoga therapy compared to those in the wait-list group as reflected by a greater decrease in Scale for Assessment of negative symptoms score. This scale measures negative symptoms on a 25 item, 6-point scale. Items are listed under the five domains of affective blunting, alogia, avolition/apathy, anhedonia/asociality, and attention. A higher score indicates greater severity.
At the end of 12 weeks of yoga
Secondary Outcomes (1)
fMRI changes
At the end of 12weeks
Study Arms (2)
Yoga arm
ACTIVE COMPARATORPatients with Schizophrenia will undergo 12 sessions of yoga. According to randomization one group of patients will start yoga immediately after recruitment ,whereas another group will go into wait list for 12 weeks after which they will also undergo Yoga treatment.
Control arm
NO INTERVENTIONHealthy volunteers who will not receive yoga.
Interventions
Eligibility Criteria
You may qualify if:
- Schizophrenia Subject
- ICD (International Classification of Diseases) 10 diagnosis of schizophrenia
- capacity to provide informed consent, as evaluated by the MacArthur Competence Assessment Tool for Clinical Research
- no other current comorbid axis I diagnosis (except nicotine abuse/dependence) and no general impaired intellectual functioning
- Healthy volunteers:
- Males and females between 18 and 45 years
- Capacity to provide informed consent
- absence of past or present psychiatric illnesses including substance abuse 4) no general impaired intellectual functioning (MMSE above24)
You may not qualify if:
- Other current comorbid axis I diagnosis (except nicotine abuse/dependence) and general impaired intellectual functioning
- History of alcohol or substance abuse or dependence in the last 12 months (with the exception of nicotine)
- Any Contraindication to MRI like metal implants or paramagnetic objects within the body or claustrophobia (only for patients undergoing fMRI at NIMHANS)
- Past history of head injury resulting in loss of consciousness or neurosurgery
- Concomitant severe medical conditions
- Change in dose of antipsychotic medication or Electroconvulsive therapy in the past 6weeks
- Pregnant or lactating -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institute of Mental Health and Neurosciences
Bangalore, Karnataka, 560029, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Naren P Rao, MD
National Institute of Mental Health and Neuro Sciences, India
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor ,Department of Psychiatry, NIMHANS
Study Record Dates
First Submitted
December 15, 2017
First Posted
December 20, 2017
Study Start
November 11, 2016
Primary Completion
June 1, 2020
Study Completion
June 1, 2020
Last Updated
August 28, 2020
Record last verified: 2020-08